Indian Pharmacopoeia Commission: Structure and Role in Formulation of IP and NFI
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32797
Indian Pharmacopoeia Commission: Structure and Role in Formulation of IP and NFI

Authors: Sanvidhan G. Suke

Abstract:

This article briefly reviews the role of Indian Pharmacopoeia Commission (IPC) for publications of Indian Pharmacopoeia (IP) and National formulary of India (NFI) to some of these anticipated changes, informs constituents about how they can remain updated about progress and upcoming modifications to official texts, and invites participation in the standards-setting process, which are helpful to the practitioners, researchers, educators and policy makers in the field of health care profession.

Keywords: Addendum, Indian Pharmacopoeia, Monograph, National Formulary of India.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1107237

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 5755

References:


[1] IPC, “Indian Pharmacopoeia Commission annual report,” 2010-11.
[2] IPC, “Indian Pharmacopoeia Commission,” Annual report, http://ipc.nic.in/printcont.asp?lid=19&EncHid (Assess on 30 November 2014).
[3] B. Mukerji, “The First Indian Pharmacopoeia,” J. Sci. Industr. Res., vol. 15, pp. 495–496, 1956.
[4] R. S. Gaud, Pharmaceutics, Pragati Books Pvt. Ltd., 2008, pp 220.
[5] SIW, “Evolution of Pharmacy and Pharmaceutical Literature,” Science Info World (SIW). December 15, 2010.
[6] P.V. Kasture, Pharmaceutics-I, Fifteenth edition, Nirali Prakashan, June 2008.
[7] IPC, “Indian Pharmacopoeia Commission”, Annual report 2011-12.
[8] S. K. Jain, V. Soni, “Bentley's Textbook of Pharmaceutics,” Kindle Edition, Elsevier Health Sciences, May-2012, pp 776.
[9] IPC, “Indian Pharmacopoeia Commission annual report,” 2011-12.
[10] IPC, “Indian Pharmacopoeia Commission”, MoHFW (Govt. of India). http://ipc.nic.in/writereaddata/linkimages/New%20Features%20of%20I P%2020107592310671.pdf (Accessed on January 12, 2015).
[11] IP, “Indian Pharmacopoeia-2014,” Seventh edition, Four volumes, Published Indian Pharmacopoeia Commission 2014).
[12] IPC, “Indian Pharmacopoeia Commission”, ERRATA-001 and 002, http://www.ipc.gov.in/index2.asp?slid=119&sublinkid=193&lang=1&E ncHid (Accessed on December 19, 2014).
[13] IPC, “Indian Pharmacopoeia Commission”, MoHFW (Govt. of India) . http://www.ipc.gov.in/index2.asp?slid=330&sublinkid=241&lang=1&E ncHid= (Accessed on January 12, 2015).
[14] IPC, “Indian Pharmacopoeia Commission”, MoHFW (Govt.. of India), http://ipc.nic.in/showfile.asp?EncHid=&lid=277 (Accessed on March 07, 2015).
[15] IPC, “Indian Pharmacopoeia Commission”, MoHFW (Govt.. of India). http://ipc.nic.in/printcont.asp?lid=53&EncHid= (Accessed on November 30, 2014).
[16] NFI, “National Formulary of India,” Fourth edition, 2011.
[17] IPC, “Indian Pharmacopoeia Commission”, MoHFW (Govt. of India). http://ipc.nic.in/index2.asp?slid=345&sublinkid=250&lang=1&EncHid (Accessed on January 12, 2015).